Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2006; 12(23): 3760-3765
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3760
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3760
Table 4 Mutation patterns of 22 advanced and metastatic small bowel GIST patients treated with imatinib meslyate
Case (n) | Mutation pattern |
2 | Deletion mutation at codon 551-556 in exon 11 |
4 | Deletion mutation at codon 557-561 in exon 11 |
8 | Deletion mutation at codon 550-5 in exon 11 |
12 | Deletion mutation at codon 563-576 in exon 11 |
13 | Deletion mutation at codon 575-576 in exon 11 |
19 | Deletion mutation at codon 569-575 in the exon 11 |
24 | Deletion mutation at of codon 555-572 in exon 11 |
1 | Deletion and insertion mutations at codons 563-572 in exon 11 |
15 | Deletion and insertion mutations at codons 557-8 in the exon 11 |
22 | Deletion and insertion mutations at codon 563-574 in exon 11 |
3 | Missense mutation at codon 556 in exon 11 |
18 | Missense mutation at codon 576 in the exon 11 |
21 | Missense mutation at codon 557 in exon 11 |
7 | Insertion mutation at codon 502-3 AY(alanine and tyrosin) in exon 9 |
9 | Insertion mutation at codon 502-3 AY(alanine and tyrosin) in exon 9 |
17 | Insertion mutation at codon 502-3 AY(alanine and tyrosin) in exon 9 |
10 | No mutation |
14 | No mutation |
20 | No mutation |
- Citation: Yeh CN, Chen TW, Wu TJ, Hsueh S, Jan YY. Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: Implications of imatinib mesylate. World J Gastroenterol 2006; 12(23): 3760-3765
- URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3760.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3760